The Calcineurin Inhibitor-Sparing (CIS) Trial - individualised calcineurin-inhibitor treatment by immunomonitoring in renal allograft recipients: protocol for a randomised controlled trial

BACKGROUND: Adequate monitoring tools are required to optimise the immunosuppressive therapy of an individual patient. Particularly, in calcineurin inhibitors, as critical dose drugs with a narrow therapeutic range, the optimal monitoring strategies are discussed in terms of safety and efficacy. Nev...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Trials
Главные авторы: Sommerer, Claudia, Schaier, Matthias, Morath, Christian, Schwenger, Vedat, Rauch, Geraldine, Giese, Thomas, Zeier, Martin
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2014
Предметы:
Study Protocol
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4301857/
https://ncbi.nlm.nih.gov/pubmed/25494823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-15-489
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы